Bio x-risk Debate: Control the Biotech Supply Chain, Not AI Progress
Justin_Halford_ · x · 2026-09-11
Responding to concerns about AI-amplified bio risk, the author calls biorisk the only plausible x-risk mechanism but argues the fix is tighter biotech supply chain control rather than banning AI progress. Since today's models — including this year's abliterated open-weights SOTA — already lower the bar for misuse, halting AI advancement buys nothing while the latent risk persists.
More from AGI Musings
- OpenAI recursive self-improvement researcher warns of 70% human extinction risk in 3 years — Yamapama · 2026-09-11
- Slide from Lenny's Summit goes viral: AI slop has never survived a real design crit — lennysan · 2026-09-11
- Jensen Huang calls AI safety critic's claims "deeply untrue", sparking trust debate — BlackHC · 2026-09-11
- Retired models get a 'retirement home' — and the AI community is uneasy about it — repligate · 2026-09-11
- AI companies sponsoring student math events is no worse than free compute for professors — soumitrashukla9 · 2026-09-11
- Mathematician volunteers to mentor three AI-assisted Mathathon student teams — soumitrashukla9 · 2026-09-11